IFF

Abstract Amorphous solid dispersions (ASDs) enable formulations to improve the solubility of poorly soluble active pharmaceutical ingredients (APIs). The amorphous...

Update, April 11th 2025 IFF Pharma Solutions, announced the launch of Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC), a range of...

Oral colon delivery has widely been pursued exploiting naturally occurring polysaccharides degraded by the resident microbiota. However, their hydrophilicity may...

Among the various 3D printing techniques, FDM is the most studied in pharmaceutical research. However, it requires the fabrication of...

Cobalamin (vitamin B12), an essential vitamin with low oral bioavailability, plays a vital role in cellular functions. This research aimed...

Abstract A comparative analysis was conducted to examine the flow characteristics of two HPMC grades and their fractions. Excipients processing...

This year CPHI Europe opens its doors in Barcelona at Fira Barcelona Gran Via. From 24th to 26th October you...

Extended release formulations play a crucial role in the pharmaceutical industry by maintaining steady plasma levels, reducing side effects, and...

3D-printing technology offers a flexible manufacturing platform with the potential to address the need of personalized dosage forms. However, quality...

Self-microemulsifying drug delivery systems (SMEDDS) are lipid-based formulations, designed to improve the solubility of poorly-water soluble drugs. Mesoporous silica is...